Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro

Yuko Miyagoe-Suzuki1, Nami Masubuchi, Kaori Miyamoto

  • 1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan. miyagoe@ncnp.go.jp

Mechanisms of Development
|December 31, 2008
PubMed